Latest Articles
- The dark side of evidence-based medicine
Clinical judgement – utilizing personal experience, analogy and extrapolation – is still necessary in a system of evidence-based medicine.
- Current issues in menopausal hormone replacement therapy
For most menopausal women, the benefits of hormone replacement therapy out-weigh the risks, despite the fears aroused by an unproven link to breast cancer.
- What does tumor shrinkage mean to the patient receiving chemotherapy?
Chemotherapy is often considered successful. if the tumor shrinks. But does tumor shrinkage alleviate symptoms and prolong life?
- Prevention of insulin-dependent diabetes mellitus: an overview of three trials
Clinicians are eagerly awaiting the results of three large-scale trials using different approaches to prevent IDDM.
- Preventive cardiology: Whose job is it? Who will pay for it? What is the best strategy?
Should cardiologists, internists, or nurse practitioners lead prevention efforts? What is the role of diet in the era of the statins?
- Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity
ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.
- Contemporary issues in cost-effective drug therapy
There is more to controlling pharmacy costs than choosing the least expensive drug. Preventing medication errors and reducing overall costs is key.